The FDA approved an innovative treatment from Amgen for patients with small cell lung cancer who have exhausted all other ...
Walgreens is once again attempting to sell its Boots pharmacies in the United Kingdom as chief executive officer Tim ...
Walgreens is expanding its specialty pharmacy services and investing in its capabilities as the company further grows its core pharmacy business to improve patient outcomes and provide greater value t ...
Walgreens is expanding its specialty pharmacy services and investing in its capabilities as the company further grows its ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips May has historically been a month of market uncertainty on ...
Walgreens is bringing all of its specialty pharmacy services into one integrated unit and expanding its offerings for patients suffering from complex chronic conditions with an investment in gene and ...
The company has long been a leader in specialty pharmacy and the treatment of rare diseases, providing services for ... top 10 in Inc. 5000 Walgreens to open cell and gene therapy pharmacy center ...
The company unveiled Walgreens Specialty Pharmacy, a division of the Walgreens Boots Alliance that will include a new 18,000-square-foot gene and cell services ... a smooth start to treatment ...
Pfizer is one of several companies to invest in the rapidly growing field of gene and cell therapies. They are one-time, high-cost treatments that target a patient’s genetic source or cell to ...